Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies

benzinga.com/news/health-care/25/06/45885869/novo-nordisk-deep-apple-launch-drug-discovery-alliance-for-weight-loss-oral-therapies

Deep Apple Therapeutics, Inc. announced on Wednesday a research collaboration and exclusive worldwide license agreement with Novo Nordisk A/S (NYSE:NVO) to discover, develop, and commercialize oral small molecule therapeutics directed at a novel non-incretin GPCR target for…

This story appeared on benzinga.com, 2025-06-11 14:40:16.
The Entire Business World on a Single Page. Free to Use →